Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QO0D
|
|||
| Former ID |
DIB010474
|
|||
| Drug Name |
H5N1 influenza vaccine
|
|||
| Synonyms |
KIB-PIA; H5N1 influenza vaccine (inactivated whole virion, egg-cultured, alum-adjuvanted); Avian influenza vaccine (inactivated whole virion, egg-cultured, alum-adjuvanted), Kitasato; H5N1 influenza vaccine (inactivated whole virion, egg-cultured, alum-adjuvanted), Kitasato
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 3 | [1] | |
| Company |
Kitasato Institute
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [2], [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Daiichi Sankyo. | |||
| REF 2 | Characterization of a whole, inactivated influenza (H5N1) vaccine. Influenza and Other Respiratory Viruses Volume 2, Issue 6, pages 261-266, November 2008. | |||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.